Transcript Highlights:

• What happens from the pharmacy, you know, from the pharmacy, from the warehouse, to the patient?
• So when you went to buy them at the pharmacy, they were seeing an average savings of $500 a year.
• a pharmacy affiliated with that PBM.
• So it allows you to use your prescription, your pharmacy. Thank you.
• So it allows you to use your prescription, your pharmacy. Thank you so much.

Bills: AB93, AB204, AB414, AB504, AB598

Keywords: public employees, police officers, benefits, appropriation, law enforcement, medical debt, collection agency, healthcare, consumer protection, financial assistance, occupational safety, air quality, greenhouse gases, employee monitoring, safety program, hemp, hemp products, cannabidiol, CBD, cannabis

Transcript Highlights:

• <00:16:41.360> benefit insurance committee um Pharmacy benefit insurance committee um Pharmacy
• artificially high prices at the pharmacy artificially high prices at the pharmacy counter<00:19:
• I was able to pull just some Anthem data from our pharmacy retail pharmacy in Campbellville for 2024.
• uh Retail Pharmacy from our uh Pharmacy uh Retail Pharmacy in<00:41:32.640> campbellville<00:
• entertained a great deal of of Pharmacy entertained a great deal of of Pharmacy legislation<00:43

Keywords: Meeting Start: 00:00 Roll Call: 00:10 SB145 Discussion: 02:23 SB145 Vote: 05:13 SB183 Discussion: 06:13 SB183 Vote: 11:37 HB413 Discussion Only: 16:15, 958, all

Summary: The House Standing Committee on Banking and Insurance met with a quorum and first took up Senate Bill 145, sponsored by Sen. David Givens. The bill would update retail installment contract statutes for automobile sales, allowing retailers with installment contracts shorter than 28 days to begin collections after three days instead of waiting for multiple missed payments, and it also harmonizes a related dollar amount in statute from $10 to $15. The committee asked no questions, and the bill received a favorable expression on a roll-call vote. The committee then heard Senate Bill 183 from Sen. Matt Nunn, with testimony from Chris Nolan of the American Property Casualty Insurance Association. The bill would require proxy advisers acting for the State Retirement System to act solely in the financial interest of current and future retirees and to avoid political or social considerations in shareholder voting recommendations. Supporters argued it would keep politics out of public pensions and align proxy advice with fiduciary duties; members praised the bill and noted Kentucky could be among the first states to adopt such a model. The committee approved the bill with favorable expression after a roll-call vote. The committee also reviewed administrative regulation 808 KAR 9:10 from the Department of Financial Institutions, with no vote required. It then took up House Bill 413, a PBM rebate pass-through bill, with testimony from Sarah Wood of the Diabetes Patient Advocacy Coalition. She said the bill would require 85% of negotiated drug rebates to be passed through to patients at the point of sale, lowering out-of-pocket costs, especially for high-rebate drugs such as insulin, while still allowing 15% to remain with plans. She cited examples from other states and argued the bill would benefit about 650,000 Kentuckians. Hope McClaflin of Anthem opposed the bill, saying it would reduce employers’ ability to use rebates to lower premiums, could disproportionately favor high-cost brand-name drug users, and could create significant costs for state and fully insured plans. Members asked questions about other states’ pass-through rates and the effect on premiums, but no final action on House Bill 413 was taken in the portion of the meeting provided.

Transcript Highlights:

• the 340b savings um contract pharmacies the 340b savings um contract pharmacies are<02:38:09.840
• by Pharmacy pharmacies preferred by Pharmacy benefits<02:41:11.359> managers<02:41:11.960>
• and if so um if it isn't a pharmacy and if so um if it isn't a contract<02:51:44.000> Pharmacy
• contract Pharmacy profits goes to four contract Pharmacy profits goes to four major<02:58:09.600>
• We have contracts with numerous pharmacies simply because we do not operate our own pharmacy.

Keywords: 1191, senate, all

Transcript Highlights:

• AB 2141 follows that same principle by creating a pharmacy-specific procedure.
• regulatory environment of pharmacy while fully preserving public protection.
• It does go well beyond traditional pharmacy practice.
• First, it confuses local pharmacies with manufacturers.
• licensees, which are pharmacies and pharmacists.

Keywords: 987, senate, all

Transcript Highlights:

• The pharmacy that filled my prescriptions for the past 25 years was the awesome pharmacy, Olden's Pharmacy
• of pharmacy.
• of pharmacy.
• benefit managers and pharmacy benefit managers are agents of insurance Pharmacy benefit managers are
• I am the President of the Massachusetts Pharmacy Association and the Director of Pharmacy at Greater

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a lengthy public hearing with testimony on a wide range of health insurance and access-to-care bills. Early testimony focused on prescription drug pricing and pharmacy reimbursement, with supporters of H. 1326 arguing that pharmacy benefit managers and MassHealth managed care arrangements reimburse independent pharmacies too little, contributing to pharmacy closures and “pharmacy deserts.” The committee also heard repeated support for H. 1151/S. 742 on cognitive rehabilitation for acquired brain injury, H. 1288/S. 716 on telehealth parity for nutrition counseling, H. 1309/S. 761 on full-spectrum pregnancy care without cost-sharing, H. 1312 on insurance coverage for doula services, H. 309 on prompt access to health care by removing deductibles for certain services, H. 809/H. 1227 on biomarker testing, H. 1162/S. 810 on reducing inequities in access to medical procedures by limiting insurer cuts tied to Modifier 25, and S. 726 on insurance coverage for mobile integrated health. Testifiers included legislators, physicians, pharmacists, dietitians, emergency and rehabilitation clinicians, and patients and family members. Supporters of the brain injury bill said cognitive rehabilitation is medically necessary, improves long-term outcomes, and can reduce institutional care and public costs; they noted the bill has been heard repeatedly and has support from the Brain Injury Commission and prior favorable committee action. Supporters of the pregnancy care and doula bills described out-of-pocket costs as a barrier to maternal health and shared personal stories of high bills and unmet support needs. Biomarker testing advocates and cancer patients said coverage gaps deny patients access to precision treatment, can lead to avoidable suffering, and should be standardized across insurers; several speakers said insurers often deny claims despite clinical benefit. Dermatology witnesses said insurers’ use of Modifier 25 cuts reimbursement for same-day evaluation and procedure visits, forcing separate appointments and increasing patient burden. Mobile integrated health supporters described home-based care as a way to reduce emergency department use and hospital readmissions, especially for patients with transportation or mobility barriers. No votes or formal committee actions were taken during the hearing itself.

Transcript Highlights:

• So we analyze prescription drug spending under the pharmacy benefit, and pharmacy benefits are typically
• So we analyze prescription drug spending under the pharmacy benefit, and pharmacy benefits are typically
• called Pharmacy administered by entities called Pharmacy benefit<00:30:46.480> managers<00:30
• Do they also sell my information to pharmacies?
• <00:48:25.559> discount your data the V first pharmacy discount your data the V first pharmacy

Keywords: 928, house, all

Summary: The working session focused on the New Hampshire Prescription Drug Affordability Board’s budget request and its recent work. Early discussion centered on a technical question about a statutory dedicated fund for donations: members asked why the budget did not show a line item for accepting donations, and DHHS CFO Nathan White explained that the statute already authorizes the fund, but because no revenue has been received yet, it does not appear in the budget. He said any future donations would go through the normal process under RSA 14:30-a, with fiscal committee and Governor and Council approval and a memo to the Department of Revenue Administration. The chair clarified that the account was not a prerequisite to soliciting donations, and White said the fund would supplement, not replace, General Fund support. Kirk Williamson, the board’s executive director, then presented the board’s mission and budget. He said the governor’s budget provides about $256,500 in the first year and slightly more in the second, all General Funds, and that the board had distributed a technical amendment to continue the executive director position. He described the board’s role as analyzing prescription drug costs, identifying savings opportunities, monitoring market trends, promoting transparency, and making recommendations to the legislature and public payers. He also emphasized that the board operates publicly, with live-streamed meetings and a stakeholder advisory council that includes unions, state agencies, Medicaid, corrections, higher education, and other stakeholders. A major topic was the board’s estimate of $6 million in potential savings, based on Medicare’s newly negotiated prices for 10 drugs. Williamson explained that the board used those federal negotiated prices as a benchmark to estimate what New Hampshire public payers might be missing by not having similar leverage, and said the board is trying to build evidence for future recommendations rather than directly setting prices. Members asked how those potential savings could become actual savings, and Williamson said the board is sharing findings through its advisory council and feedback loops, though it has not yet sent a formal recommendation letter to specific purchasers. He also discussed the difference between pharmacy-benefit spending, which relies heavily on PBM-negotiated rebates, and medical-benefit spending, which is administered differently and is being added to the board’s next report. Williamson highlighted other work, including a model on Humira and a pending legislative effort to improve biosimilar competition, plus a proposed state-backed pharmacy savings card that would be no cost to the state and could save users about $240 per prescription based on Connecticut’s experience. No votes were taken during the session.

Transcript Highlights:

• , 1,600 pharmacies...
• , 1600 PHARMACIES  370 Closed last year.
• Chair McClure: Eric Larson, Florida Pharmacy Association, is here for information.
• My name is Eric Larson, also an independent pharmacy owner in Central Florida.
• A small town has one pharmacy, and you have an hour drive to the next one?

Summary: The committee first took up CS/House Bill 981, which would restore the Ocklawaha River and related natural resources. Supporters, including environmental groups, Save the Manatee Club, business owners, and Reunite the Rivers advocates, argued the bill would improve manatee habitat, fish passage, flood protection, tourism, and long-term economic returns while reducing dam maintenance costs. Opponents and skeptics focused on concerns about water quality, nutrient loading in the St. Johns River, loss of the Rodman Reservoir’s habitat and water-supply value, and potential ecological and economic harms. Members in debate largely supported the restoration effort, and the bill was reported favorably on a unanimous vote. The committee then heard HB 697, the PRICE Act, which would use international reference pricing to set a drug cost benchmark, address pharmacy benefit manager practices, and require health plans to keep drug prices stable for the year. The sponsor said the bill would lower costs and improve access, especially for uninsured Floridians. Supporters, including independent pharmacists, argued PBMs are squeezing pharmacies and that the bill could help lower prices. Opponents from BioFlorida and PhRMA warned the proposal could disrupt the national drug supply chain, fail to pass savings to patients, and lead to shortages, reduced access, and less innovation. After debate, the bill passed favorably, with Rep. Chambliss voting no. The committee also considered CS/HB 1081, which was amended to include private colleges and universities with NCA designation in the program. After brief discussion and support from United Way Miami, the committee reported the bill favorably. Finally, CS/HB 177 was introduced as a framework for Florida’s regional councils to cross-assign bills among regions; it received supportive testimony and was also reported favorably. The meeting then adjourned.

Transcript Highlights:

• > got<00:01:24.880> our not just pharmacies, we've got our not just pharmacies, we've got
• we also have pharmacy benefit managers. we also have pharmacy benefit managers.
• <00:01:35.200> benefit That's that's a big pharmacy benefit That's that's a big pharmacy benefit
• ><00:45:00.960> the<00:45:01.200> um pharmacy benefit manager but the um pharmacy benefit
• investigators is a pharmacy. investigators is a pharmacy. >> Yes.<00:54:10.160> Yes.

Keywords: Appropriations - Room 409, 28 January, 2026; 1:30 P.M., 925, all

Summary: The committee heard budget presentations from the Mississippi Board of Pharmacy and the Mississippi State Board of Chiropractic Examiners, followed by the physical therapy board. The Pharmacy Board said it licenses pharmacists, technicians, students, and many facilities and supply-chain entities, including wholesalers, manufacturers, 3PLs, PBMs, and nonresident compounders. Its main requests were a 3% salary increase for specialized staff, about $118,000 for contract help to evaluate pharmacists with substance abuse or mental health issues under a recently passed public health bill, and additional IT spending authority for system upgrades and cloud migration. Members discussed the board’s role in protecting the public, vetting out-of-state facilities, and the need to keep sensitive data secure; no vote was taken. The Chiropractic Examiners board described itself as a small, contract-staffed agency with about 700 active licenses and a database system that is no longer supported by Microsoft. It said it had requested about $173,000, but the legislative budget recommendation was $134,000, and it needs roughly $40,000 more to upgrade or rebuild the system, including security fixes and online renewal capability. Members focused on the cybersecurity risk of using unsupported software and the need to protect personal information; the board also noted that its licensing data does not include banking information because payments are handled through the state portal. The Physical Therapy Board said it regulates physical therapists and physical therapist assistants, with 4,242 licenses and 252 complaints in the last fiscal year, and that demand for the profession continues to grow. Its requests included $6,000 in salary progression for long-serving staff, about $360 more in PDM salary authority, and roughly $38,610 for a one-time upgrade to its LMS licensing system, plus related cloud-migration costs. Senators noted the board’s strong reputation, discussed the burden of annual or biennial renewals, and supported the technology upgrade because the current system is no longer supported and could create liability risks if not addressed.

Transcript Highlights:

• the same amount as they pay an affiliated pharmacy.
• And then the PBMs negotiate with the retail pharmacies in secret.
• We're losing at least two neighborhood pharmacies every week this calendar year.
• In the past year, 1,600 pharmacies closed, both chain pharmacies and small mom-and-pop pharmacies.
• , and they're sending the lowest reimbursement to my client's pharmacies.

Transcript Highlights:

• It allows for CGMs to be billed by both pharmacy and durable medical equipment providers.
• Pharmacy and durable medical equipment providers. It is already live with our system.
• We're also setting up a process by which we allow the pharmacy alert the pharmacy that they cannot bill
• But DME providers submit to AFMC... ...or all pharmacy PAs.
• And now what you're saying is they're going to go through pharmacy for these.

Summary: The committee reviewed a series of Arkansas Medicaid and Department of Health rules, many implementing 2025 acts. Early items covered presumptive eligibility and Medicaid policy updates, including adding a definition of fictive kin for foster children and changing the disability onset age for ABLE accounts from 26 to 46. Another rule clarified that continuous glucose monitors may be billed by both pharmacies and durable medical equipment providers, with committee members questioning prior authorization timing, system lag, and a fiscal impact estimate of about $3 million over two years; the rule was reviewed, but members requested additional cost breakdowns. Other Medicaid-related rules addressed an RSV vaccine administration fee increase, an ET3 telemedicine exemption for ambulance treat-triage-transport services, a dental rate increase under Act 1025, expanded physical therapy access, and the Healthy Moms, Healthy Babies package covering doulas, lactation consultants, remote monitoring, and expanded prenatal testing. Most were reviewed without objection after brief discussion or no questions.

Transcript Highlights:

• Next, we'll take up Tab 6, Senate Bill 1256 on pharmacy audits by Senator Grawl.
• , and fairly across all types of pharmacies.
• independent pharmacies, PBM-owned pharmacies, and PBM-affiliated pharmacies.
• integrity of the pharmacy system, but without destroying...
• Fair audits protect the integrity of the pharmacy system, but without destroying pharmacy practices over

Summary: The Banking and Insurance Committee took up several bills, beginning with CS/SB 326, which modernizes Florida’s curator statute in probate law by clarifying when curators may be appointed, what they may do, and the oversight required. The bill was reported favorably without opposition. The committee then heard SB 1256 on pharmacy audits, which would require PBM audits of pharmacies to follow uniform standards and provide due process protections; pharmacists testified in support, describing current audits as burdensome and conflicted. That bill was also reported favorably. Members next considered CS/SB 598 on funeral, cemetery, and consumer services. An amendment was adopted removing provisions on civil damage caps and phasing out direct disposers, and the bill was then reported favorably. SB 632, dealing with transportation network company insurance, would set coverage requirements for the period after a ride is accepted but before pickup; an opponent argued the existing insurance framework should not be reduced, but the bill passed on a divided vote and was reported favorably. CS/SB 786 on trusts, creating a nonjudicial process to close uncontested trusts and discharge trustees, was supported by banking and legal groups and reported favorably. The committee then took up CS/SB 1110 on Medicaid, health insurance, and HMO coverage for orthotics and prosthetics. A delete-all amendment clarified eligible recipients, and the bill drew extensive emotional testimony from amputees, parents, and advocates describing the high cost of activity limbs and the benefits for children’s health and participation. Several senators praised the testimony and the policy, and the bill was reported favorably. Finally, SB 1588 on legal tender refined last session’s gold-and-silver law, and SPB 7044 created related public-records exemptions for custodians of gold and silver; both were reported favorably, with SPB 7044 adopted as a committee bill. The meeting ended with senators recording additional affirmative votes on selected bills and adjournment.

Transcript Highlights:

• These restrictions often limit health centers to one in-house pharmacy or one contract pharmacy location
• ICE. 340B drugs at one in-house pharmacy.
• The contract pharmacy restrictions also meant clinic systems can't contract with multiple pharmacies
• More contract pharmacy arrangements would guarantee access in low-income areas, which helps keep pharmacies
• contract pharmacies.

Summary: The Assembly Health Committee met on April 22 and took up a special order of bills focused largely on prior authorization and utilization management in health care. The chair framed the discussion as part of a broader legislative effort to reduce delays and barriers to care, especially in behavioral health, chronic disease management, cancer treatment, and rehabilitation services. AB 384 by Assembly Member Connolly would prohibit prior authorization for inpatient mental health or substance use emergency admissions and related physician care; supporters said it would prevent dangerous delays in crisis care, while insurers and health plans warned about fraud, abuse, and ambiguity around residential treatment facilities. The bill was moved on a due pass as amended motion and passed the committee on a party-line style vote, with Republicans largely absent or not voting. The committee then heard AB 510 by Assembly Member Addis, which would require health plans, upon request, to provide a peer reviewer of the same or similar specialty when a treating provider appeals a prior authorization denial or modification. Supporters argued that specialty-matched review would make appeals fairer and more clinically informed; opponents said the requirement was too rigid and that timelines and electronic submission rules needed changes. After discussion about the need for timely, specialty-specific review, the bill was approved on a due pass as amended motion and placed on call. AB 539 by Assembly Member Schiavo would extend prior authorization approvals to one year or the duration of the physician’s prescribed treatment for chronic conditions; supporters cited repeated denials and treatment interruptions, while opponents raised concerns about overbreadth, fraud, and the need for shorter validity periods. The bill was also passed as amended and placed on call. The committee next considered AB 669 by Assembly Member Haney, which would bar concurrent and retrospective review for the first 28 days of medically necessary substance use disorder treatment and limit prior authorization for related outpatient medications. The bill was presented with a powerful personal story from Ryan Matlock’s mother about her son’s death after an insurer cut off treatment early; supporters said the measure would keep patients in care long enough to stabilize, while opponents argued it would reduce oversight and could allow lower-quality or non-evidence-based care. The bill was moved on a due pass as amended motion and placed on call. Finally, AB 512 by Assembly Member Harabedian would shorten prior authorization response times to 24 hours for urgent requests and 48 hours for non-urgent requests; supporters said delays can worsen outcomes, while opponents warned the timelines were unrealistic and could increase administrative burdens and safety issues. The bill was approved as amended and placed on call. AB 574 by Assembly Member Mark Gonzalez was then heard; it would allow up to 12 medically necessary physical therapy sessions for a new episode of care without prior authorization, with supporters emphasizing stroke and neurological recovery and opponents warning of reduced oversight and unnecessary care. The transcript ends during testimony on AB 574, before final action is shown.

Transcript Highlights:

• , and we call that a pharmacy desert.
• , and we call that a pharmacy desert.
• that if that one pharmacy closed, that area would ...become a pharmacy desert.
• And we call that a near pharmacy desert.
• types of pharmacies?

Keywords: 995, all

Summary: The Joint Committee on Ways and Means held a Health and Human Services budget hearing in Clinton, with opening remarks from Chairs Meg Kilcoyne and Robin Kennedy, local officials, and many House and Senate members introducing themselves. The hearing focused on Governor Healey’s FY27 EOHHS and MassHealth budgets, with repeated themes of rising health care costs, federal funding uncertainty, workforce shortages, and access to care in underserved regions. Members also raised concerns about primary care shortages, rural and regional disparities, behavioral health access, maternal health, food insecurity, and the impact of federal policy changes on Massachusetts programs. EOHHS Secretary Kiame Mahaniah said the FY27 EOHHS budget totals $33.7 billion, reflecting mostly non-discretionary growth from health care costs, labor costs, caseload increases, and provider rate pressures. He highlighted targeted investments in foster care, family resource centers, maternal health, youth services, nutrition programs, immigrant legal services, and human service workforce rates, while warning that federal actions could strip roughly $3.5 billion annually from the state’s health care funding. In response to questions, he defended the administration’s cooperation with federal audits and program integrity efforts, discussed the primary care crisis, and said the state is trying to preserve core services while preparing for a more difficult FY28 budget cycle. MassHealth Undersecretary Mike Levine then described two major FY27 challenges: double-digit cost growth and the expected effects of the federal One Big Beautiful Bill Act. He said MassHealth’s proposed $22.7 billion gross budget includes a 7.5% increase and relies on a moratorium on new expansions plus targeted reductions, including a $1,000 annual adult dental cap, ending GLP-1 coverage for weight loss only, reducing care management to peer-state levels, and work groups to slow growth in PCA, adult foster care, and adult day health spending. Members questioned the impact on Boston Health Care for the Homeless, preventive care, and regional access; Levine said the changes are meant to preserve sustainability, that children and certain disabled populations remain protected, and that the administration will continue working with providers, advocates, and the Legislature on implementation and longer-term reforms.

Transcript Highlights:

• aren't being passed down at the pharmacy aren't being passed down at the pharmacy counter.<01:09
• <01:20:10.560> and<01:20:10.800> the pharmaceut pharmacy and the pharmaceut pharmacy
• one contract pharmacy per health center. one contract pharmacy per health center.
• pharmacy has no status as a contract pharmacy has no impact<01:48:23.119> on<01:48:23.360>
• Pharmacies. It's created pharmacy deserts all across the state.

Keywords: 1187, senate, all

Transcript Highlights:

• pharmacy benefit managers to ensure that they manage that health plan's pharmacy benefit.
• , online pharmacies, specialty pharmacies, and then you have health insurers.
• Online pharmacies, specialty pharmacies, and then you have health insurers.
• And they own the pharmacies, too. They are starting to own the pharmacy. So that's...
• , mail order pharmacy, and independent pharmacies in the community.

Keywords: 1184, house, all

Transcript Highlights:

• We also partner with our MedImpact pharmacy benefit manager, um, because they look at pharmacy first
• with our with Med impact our Pharmacy with our with Med impact our Pharmacy benefit<00:30:16.840
• > comes<00:30:20.960> to Pharmacy first before Pharmacy comes to Pharmacy first before Pharmacy
• organizations so we have one uh Pharmacy organizations so we have one uh Pharmacy benefit<00:36:
• claims activity we also have a pharmacy claims activity we also have a pharmacy and<00:37:15.160

Keywords: 958, all

Summary: The subcommittee met to review the Department for Medicaid Services’ program integrity work. Commissioner Lisa Lee and Program Integrity Director Jennifer Dudinsky outlined Kentucky Medicaid’s structure, funding, enrollment, and spending, including FMAP rates, the size of the Medicaid and KCHIP populations, the number of providers, and 2024 expenditures. They also described the managed care and fee-for-service populations, noting that managed care serves most members while fee-for-service is concentrated in long-term care and waiver populations. Most of the discussion focused on fraud, waste, abuse prevention, and provider oversight. The department described its provider enrollment and certification checks, revalidation requirements, site reviews, fingerprinting for some high-risk providers, and termination grounds such as false application information, Medicare actions, unreported ownership changes, and abandonment of a provider number. Members asked about nonprofit ownership reporting, MCO fraud oversight, and how the department tracks unusual CPT code utilization, especially in behavioral health. The department said it uses data analytics, audits, policy review, and collaboration with behavioral health staff to monitor those trends. Dudinsky explained the division’s four branches: provider licensing and certification, audits and compliance, recovery, and third-party liability/estate recovery. She described prepayment and postpayment audits, referrals of credible fraud allegations to the Attorney General, monthly meetings with the AG’s office, and coordination with the Office of Inspector General, CMS, HHS OIG, MCOs, and other partners. She also explained payment suspensions, stand-downs during law enforcement investigations, and recovery efforts for overpayments, provider/member fraud, and third-party liability. The department said its recovery and avoidance efforts produced more than $251 million in savings so far in 2025. No votes or formal actions beyond approving the minutes were taken.

Transcript Highlights:

• Madam President and members of the Senate, this bill is about pharmacy benefit managers.
• So, brief tutorial: what exactly is a pharmacy benefit manager, or PBM?
• In addition, they own pharmacies and specialty pharmacies and set the terms, conditions, and reimbursement
• rates for their direct competitors, which are independent, small business pharmacies.
• For reference, 19-02.1 was actually the Board of Pharmacy and Health and Human Services Code.

Keywords: 908, all

Summary: The Senate opened with prayer, the Pledge, a quorum call, and approval of journal corrections. It then handled several House messages, appointing conference committees on Senate Bills 2004 and 2006 and House Bills 1018, 1019, and 1363, and re-referring House Bill 1216 to Appropriations. The chamber also adopted amendments to House Bill 1601, which would have expanded special assistant attorney general authority for certain offices, but the bill failed on final passage after strong opposition centered on preserving the Attorney General’s control and avoiding a solution in search of a problem. A major portion of the day focused on education funding. House Bill 1369 was amended to raise per-pupil aid from 2% and 2% to 3% and 3% and to increase the school construction loan transfer from $75 million to $100 million; supporters said this would help local schools and military base projects, while opponents raised questions about special education placement language and state coordination. The bill passed 44-3. House Bill 1013, the DPI budget, was also amended extensively to adjust staffing, funding sources, grants, meal assistance, teacher training, and other education programs; it passed 45-2. House Bill 2234, dealing with Choice Ready grants, was amended to shift funding away from general funds and toward federal or other sources, but then failed on final passage after the sponsor urged a red vote. The Senate also approved House Bill 1482, restricting bond and indebtedness elections for counties, cities, school districts, and park districts to primary or general election days, and House Bill 1332, creating a value-added agriculture facility incentive program with an emergency clause. House Bill 1010, the Insurance Department budget, passed unanimously after amendments reflecting the merger of the Securities Department into Insurance and adding staff and fee changes, while House Bill 1011, the separate Securities Department budget, failed because its funding was already included in HB 1010. House Bill 1584, a major pharmacy benefit manager reform bill, passed with an enforcement fund and new licensing/enforcement structure despite debate over ERISA and market transparency. In other action, the Senate concurred in House amendments and passed Senate Bills 2226, 2230, 2069, 2082, 2387, 2385, and 2186, with SB 2186 on parenting time interference and a child custody task force passing 27-20 after debate over whether the issue should be left to the courts. Senate Bill 2234, on Choice Ready grants, and Senate Bill 2243, on driver’s license points and traffic penalties, both failed after concurrence motions were adopted but final passage votes were overwhelmingly negative. The chamber also advanced Senate Bill 2291 to conference committee consideration near the end of the transcript.

Transcript Highlights:

• of Pharmacy rules and regulations and is bigger, right?
• Centered and not contract pharmacy or one of these other providers.
• In the International District, there's a food desert, there's a pharmacy desert.
• Representative, and Madam Chair, it's the Board of Pharmacy.
• Have you considered including this in the Pharmacy Act instead?

Transcript Highlights:

• or from a pharmaceutical distributor or a compounding pharmacy.
• Because I was—I worked in a pharmacy in a correctional institute.
• I mean, is there an interface with pharmacies at all or pharmacy? Yeah.
• Unfortunately, not with DPH, but it's with a pharmacy that I can.
• No, because I think I would look more like the legislative route than the Board of Pharmacy.

Keywords: 995, all

Summary: The working group on best practices for oversight and enforcement met for its first session and focused on xylazine, including its legal veterinary uses, its appearance in the illicit drug supply, and whether it should be classified as a controlled substance. Members discussed the distinction between pharmaceutical-grade and non-pharmaceutical-grade xylazine, the role of international/illicit sourcing, and the limits of state-level regulation if the substance is already being added to fentanyl or other drugs outside the Commonwealth. The Department of Public Health representative summarized the agency’s view that scheduling xylazine could follow the “ironclad law of prohibition” and push the market toward other, potentially worse substances, and said DPH opposed straight scheduling in favor of education, support, and harm-reduction approaches. Veterinary members explained how xylazine is used in large-animal and research settings, why it is useful, and why federal-style scheduling could create practical burdens for veterinarians who work in the field. They also described reversal agents such as yohimbine and atipamezole (Antisedan), and noted that xylazine is not commonly used in small-animal practice. Several members raised questions about how much xylazine is actually used legally in Massachusetts, whether boards of pharmacy or distributors could provide useful data, and what other states have done. Arizona and Florida were mentioned as possible examples for further research, along with the need to examine stakeholder opposition and any effects on legitimate veterinary practice. The group agreed to divide into two subgroups: one focused on oversight and regulation of production/distribution, and another on whether xylazine should be classified as a controlled substance and what penalties, if any, should apply. Staff said they would circulate notes, a draft PowerPoint template, and a shared folder, with members asked to submit materials by December 2, draft materials due December 4, and final approval by December 9 ahead of the next public meeting on December 11. The meeting ended with a motion to adjourn, a second, and unanimous closure.

Transcript Highlights:

• benefit manager from paying its affiliated pharmacies more than non-affiliated pharmacies.
• Additionally, it prohibits them from paying their own pharmacies more than they pay the pharmacies in
• what the patients will pay at each pharmacy and what each pharmacy will be reimbursed for that drug.
• Local pharmacies are However, PBMs don't treat all of their in-network pharmacies the same.
• I own White Mountain Pharmacy in Show Low and another remote dispensing pharmacy in Overgaard.

Bills: SB1052, SB1115, SB1118, SB1120, SB1121, SB1124, SB1171, SB1172, SB1174, SB1175, SB1214, SB1233, SB1235, SB1316, SB1345, SB1372, SB1399, SB1458, SB1494, SB1496, SB1564, SB1602, SB1621, SB1628, SB1630, SB1631, SB1668, SB1672, SB1814, SB1821

Keywords: assisted living, health care, hyperbaric oxygen therapy, physician orders, informed consent, AHCCCS, remote work, state agency, employment, public health, housing, zoning, middle housing, urban development, duplexes, triplexes, fourplexes, townhomes, historic preservation, radiation protection

Summary: The committee first heard Senate Bill 1121, which would prohibit hospitals from requiring lead aprons for cardiac catheterization staff when a radiation protection system is in place, while still allowing hospitals to require aprons outside the designated safety zone or when exposure levels warrant additional protection. An amendment added flexibility for radiation safety officers to require lead or other PPE if exposures approach occupational limits and removed expedited rulemaking language. Supporters, including the sponsor and interventional cardiologists, argued the devices reduce radiation and orthopedic injuries and improve recruitment and retention; hospital groups shifted to neutral after the amendment. The committee adopted the amendment and passed SB 1121 on a 9-2 vote. The committee then considered Senate Bill 1120, which would require hospitals performing cardiac catheterization procedures to equip at least 50% of those rooms with radiation protection systems by 2027. Supporters said the systems protect clinicians from radiation and long-term injury, while opponents, including hospital and radiology groups, argued the bill was overly prescriptive, could create a captive market, and might not fit all rooms or procedures. After adopting a children’s hospital exemption amendment, the committee passed SB 1120 on a 6-6 vote, with the chair breaking the tie in favor of the bill. Senate Bill 1118, an appropriation measure tied to the radiation protection system proposal, was also advanced after brief discussion, passing 6-5. The committee then took up Senate Bill 1214, which would create guardrails for non-FDA-approved stem cell and regenerative therapies, including provider standards, informed consent, advertising limits, reporting requirements, and a private right of action for violations. Supporters described it as a patient-protection and access bill, while testimony emphasized concerns about unregulated “bad actors” and patients traveling out of state for treatment. The committee adopted an amendment removing a reference to the National Law and passed SB 1214 on a 9-3 vote. The transcript then began discussion of SB 1630, which would create a Medicaid-funded home and community-based service benefit for adults with serious mental illness, with AHCCCS taking a neutral position and estimating a significant fiscal impact.